Doximity Beats Wallstreet Expectations

Doximity (DOCS) has shocked Wall Street by beating Q4 expectations by 4.7%. On top of that, its non-GAAP profit was 34% above analyst's expectations. 

Notable points

DOCS seemed to have absolutely crush Wall Street analysts in multiple sectors. For starters, their adjusted operating income was estimated to be $81.85 million when it was really a whopping $100.4 million. Not only that but their EBITA was also way above expectations by about $28 million. There are multiple other sectors that they beat expectations in.

Should You Invest?

DOCS is definitely a stock to consider investing in. The reason lies within the long-term growth. DOCS has continued to put up good numbers of several years now. This is important because a majority of companies do not see these consistent numbers in the same way that DOCS does. Looking back at the last 3 years the sales growth compounded to about 20.2%. 

Via StockStory

Analysts are expecting DOCS revenue to grow a little over 6% and judging by the way they have been beating analysts; this stock is worth looking into.